Olanzapine Use in Elderly Patients with Bipolar Disorder

Introduction to Olanzapine Therapy

The American College of Oncology recommends that olanzapine be prescribed to elderly patients with bipolar disorder with caution and at a reduced dose of 2.5-5 mg, considering the increased risk of side effects in this population 1, 2

Olanzapine is approved for the treatment of acute manic episodes in bipolar disorder I in adult patients, as recommended by the American Academy of Child and Adolescent Psychiatry 3, 4

The recommended initial dose for elderly patients is 2.5-5 mg orally once daily, usually at night, as suggested by the American College of Oncology 1, 2
A dose reduction is necessary for elderly patients and those with impaired liver function, according to the American College of Oncology 2

Olanzapine should be used with caution in elderly patients due to the increased risk of side effects, as warned by the National Comprehensive Cancer Network 5, 1
There is a warning about the increased risk of death in elderly patients with psychosis related to dementia, as indicated by the FDA 5

Common side effects include somnolence, fatigue, and sleep disturbances, as reported by the National Comprehensive Cancer Network 5, 1
Orthostatic hypotension is a concern, as noted by the American College of Oncology 1, 2
Metabolic effects, such as weight gain and hyperglycemia, can occur with long-term use, as cautioned by the National Comprehensive Cancer Network 5, 2
The risk of falls is increased, as warned by the American College of Oncology 2, 6
Rare but serious skin reactions, such as DRESS syndrome, can occur, as reported by the National Comprehensive Cancer Network 5

Caution should be exercised when combining olanzapine with metoclopramide, phenothiazines, or haloperidol due to the risk of excessive dopamine blockade, as advised by the National Comprehensive Cancer Network 5
Combining olanzapine with benzodiazepines increases the risk of excessive sedation and respiratory depression, as warned by the American College of Oncology 1, 7

Assess the risk-benefit ratio for the individual patient, as recommended by the American College of Oncology 1
Start with a low dose of 2.5 mg orally once daily and titrate slowly as needed, based on clinical response, as suggested by the American College of Oncology 1, 2
Regularly monitor metabolic parameters, orthostatic hypotension, sedative effects, and the risk of falls, as advised by the National Comprehensive Cancer Network and the American College of Oncology 5, 1, 2, 6